Celcuity
Dr. McGlennen is President and Medical Director of Access Genetics, a molecular diagnostics company he cofounded in 2001. Previously he was an Associate Professor at the University of Minnesota. He also serves as Celcuity’s Laboratory Medical Director.
This person is not in the org chart
This person is not in any offices
Celcuity
Celcuity is a clinical-stage biotechnology company seeking to extend the lives of cancer patients by pursuing an integrated companion diagnostic (CDx) and therapeutic (Rx) strategy that leverages the CELsignia CDx platform.